Q2 2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: TIANYU PHARM(300702) the Revenue is 1.199 B (+48.38%);the EBIT is 110.9 M (+128%);the EPS is 0.179 (-1.74%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
1.20B48.38%
----
----
EBIT
0.11B128.02%
----
----
EPS
0.17911.74%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf